Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer (EXAM)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2012 by Exelixis.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Exelixis
ClinicalTrials.gov Identifier:
NCT00704730
First received: June 23, 2008
Last updated: May 24, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2013
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
No publications provided by Exelixis

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):